Literature DB >> 30831109

A Review of the Management of Pulmonary Atresia, Ventricular Septal Defect, and Major Aortopulmonary Collateral Arteries.

Jerome Soquet1, David J Barron2, Yves d'Udekem3.   

Abstract

BACKGROUND: The management of pulmonary atresia with ventricular septal defect (PA/VSD) and major aortopulmonary collateral arteries (MAPCAs) has significantly changed over the past 20 years. Unifocalization and rehabilitation have been described as diametrically opposed strategies. An updated review focused on the management of this complex and rare condition is needed.
METHODS: Articles related to PA/VSD/MAPCAs issued until December 2017 were screened. Twelve main studies published in the modern era (since 2000) were selected and analyzed.
RESULTS: Unifocalization and rehabilitation respectively focus on the mobilization of collateral arteries and the growth of native pulmonary vessels. A third strategy, called "combined strategy," was distinguished from the review of the literature. Surgical cohorts and methods of data reporting were found to be heterogenous. Outcomes, regardless of the strategy, have transformed the natural history of the condition, with a complete repair rate of approximately 80% and low rates of early and late mortality. Patients with the most unfavorable anatomy (absent central pulmonary arteries and hypoplastic MAPCAs) remain a challenge and are still left palliated.
CONCLUSIONS: Variable surgical strategies are used in the management of PA/VSD/MAPCAs. Most teams report a repair rate of 70% to 80% and a mortality rate lower than 10%. Standardization in data reporting is necessary to better compare the existing strategies.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30831109     DOI: 10.1016/j.athoracsur.2019.01.046

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Accuracy of Fetal Echocardiography in Defining Pulmonary Artery Anatomy and Source of Pulmonary Blood flow in Pulmonary Atresia with Ventricular Septal Defect (PA/VSD).

Authors:  Iman Naimi; Michele Clouse; Bhawna Arya; Jeffrey A Conwell; Mark B Lewin; Aarti H Bhat
Journal:  Pediatr Cardiol       Date:  2021-03-08       Impact factor: 1.655

2.  Patient-Specific 3-Dimensional-Bioprinted Model for In Vitro Analysis and Treatment Planning of Pulmonary Artery Atresia in Tetralogy of Fallot and Major Aortopulmonary Collateral Arteries.

Authors:  Martin L Tomov; Alexander Cetnar; Katherine Do; Holly Bauser-Heaton; Vahid Serpooshan
Journal:  J Am Heart Assoc       Date:  2019-12-10       Impact factor: 5.501

3.  Fate of the Arterial Origin of Major Aortopulmonary Collateral Arteries After Unifocalization.

Authors:  P C van de Woestijne; J A A E Cuypers; W A Helbing; A J J C Bogers
Journal:  World J Pediatr Congenit Heart Surg       Date:  2021-03

4.  Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries: A Tailored Approach in a Developing Setting.

Authors:  Ming-Hui Zou; Li Ma; Yan-Qing Cui; Huai-Zhen Wang; Wen-Lei Li; Jia Li; Xin-Xin Chen
Journal:  Front Cardiovasc Med       Date:  2021-04-14

5.  Establishment of a Dihydrofolate Reductase Gene Knock-In Zebrafish Strain to Aid Preliminary Analysis of Congenital Heart Disease Mechanisms.

Authors:  Ke Gong; Ting Xie; Yifeng Yang; Yong Luo; Yun Deng; Kun Chen; Zhiping Tan; Hui Guo; Li Xie
Journal:  Front Cardiovasc Med       Date:  2021-12-15

6.  Identification of Rare Variants in Right Ventricular Outflow Tract Obstruction Congenital Heart Disease by Whole-Exome Sequencing.

Authors:  Yue Zhou; Kai Bai; Yu Wang; Zhuo Meng; Shuang Zhou; Shiwei Jiang; Hualin Wang; Jian Wang; Mei Yang; Qingjie Wang; Kun Sun; Sun Chen
Journal:  Front Cardiovasc Med       Date:  2022-01-24

7.  Staged correction of pulmonary atresia, ventricular septal defect, and collateral arteries.

Authors:  Pieter van de Woestijne; Mostafa Mokhles; Ingrid van Beynum; Peter de Jong; Jeroen Wilschut; Ad Bogers
Journal:  J Card Surg       Date:  2022-02-09       Impact factor: 1.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.